Clinical trial
Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In…
NCT00174200 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174200 |
|---|---|
| Title | Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone |
| Official title | A Randomized, Double-Blind, Crossover Add-On Study To Assess The Differential Sensitivity Of 2 Spatial Working Memory Tests (The Groton Maze Learning Test [GMLT] And The Motor Delayed Response Test [MDR]) In Non-Agitated, Antipsychotic Drug-Naive First-Episode Schizophrenic Or Schizophreniform… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Risperidone 2 mg |
| Enrollment | 20 |
| Start date | Dec 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 15, 2008 |
| Countries | Canada, Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: